Sign up
Quantellect · Congress · Trade Detail
MJNMead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS
RepublicanHouse

Lamar Smith sold Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN)

Lamar Smith (R-TX), a U.S. Representative, has disclosed 8 trades in Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN) since 2014, 3 purchases and 5 sales, worth an estimated $64K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Lamar Smith sold $1,001 - $15,000 of Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN) on February 3, 2017. Since that trade, MJN is up +0.00% against the S&P 500 up +274.58%, an outperformance of -274.58%.

Across these filings, Lamar Smith has been a net seller of MJN (a buy-to-sell ratio of 0.60). The most recent disclosed MJN transaction shown was dated February 23, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

MJN trades
8
Disclosed Vol
$64K
Buys
3
38%
Sells
5
63%
Buy / Sell
0.60
ratio
First → Last
2014–2017

Lamar Smith's MJN trades vs the price

MJN is up +0.00% since Lamar Smith sold on February 3, 2017, versus +274.58% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+274.58%
Outperformance vs S&P 500
-274.58%

All Lamar Smith MJN trades

TradedTypeSizeReturnEst. profit
February 23, 2017SELL$1,001 - $15,000N/A
February 3, 2017SELL$1,001 - $15,000N/A
September 30, 2016BUY$1,001 - $15,000N/A
July 29, 2016BUY$1,001 - $15,000N/A
July 26, 2016BUY$1,001 - $15,000N/A
October 8, 2015SELL$1,001 - $15,000N/A
August 5, 2015SELL$1,001 - $15,000N/A
August 28, 2014SELL$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Lamar Smith & MJN trading FAQ

Is it legal for Lamar Smith to trade Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Lamar Smith sell MJN?

Lamar Smith disclosed a sale of $1,001 - $15,000 of Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN) on February 3, 2017, according to public STOCK Act filings.

How has MJN performed since Lamar Smith's trade?

Since Lamar Smith sold MJN on February 3, 2017, the stock is up +0.00%, versus +274.58% for the S&P 500 over the same period, an outperformance of -274.58%.

How many times has Lamar Smith traded MJN?

Lamar Smith has disclosed 8 MJN trades since 2014 (3 purchases and 5 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional MJN trades?

Quantellect tracks every disclosed congressional trade in Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS (MJN) on the Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTS congressional trading page, which aggregates filings across all members of Congress.

Lamar Smith's MJN tradesAll congressional filings for Mead Johnson Nutrition Company (MJN) F ILINg S TaTUS : New S UbHoLdINg o F : MERRILL LYNCH INVESTMENT aCCoUNTSLamar Smith's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.